Prognosis in meningoencephalitis of unknown origin in dogs: Risk factors associated with survival, clinical relapse, and long-term disability
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.17037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2024. Verfasst von Rita Gonçalves und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Science, Small Animal Teaching Hospital, University of Liverpool, Neston, UK. Hauptthemen laut MEDLINE: Dog Diseases, Meningoencephalitis, Recurrence. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Meningoencephalitis of unknown origin (MUO) comprises a group of noninfectious inflammatory diseases affecting the central nervous system of dogs. Previous studies have reported individual risk factors for survival but prognostication for MUO remains challenging.
Objectives
Identify clinical prognostic variables in dogs with MUO. Animals A retrospective study of 447 dogs presented to 2 UK referral hospitals and diagnosed with MUO.
Methods
Medical records of dogs diagnosed with MUO were retrospectively reviewed. Multivariable logistic regression was used for the identification of risk factors for survival and Cox proportional hazards analysis for the identification of risk factors for clinical relapse.
Results
Eighty-two percent (366/447) of dogs with presumptive MUO survived to discharge and 63.5% (284/447) were alive at 6 months; 36% of the latter (103/284) had persistent neurological deficits. Breed (pugs; P = .03), epileptic seizures (P < .001), paresis (P < .001), and higher neurodisability scale (NDS) score (P < .001) at presentation were negatively associated with survival to 6 months. Dogs with persistent deficits had higher NDS scores on presentation (P = .001). Median follow-up time was 11 months (interquartile range [IQR], 1-24) and 50.6% (160/316) relapsed during treatment (median time to relapse, 7 months; IQR, 2-15). Incomplete resolution of the clinical signs during the 6 months after diagnosis (P < .001), higher NDS score (P < .001), and longer duration of the clinical signs (P < .001) were associated with relapse. Conclusions and Clinical Importance Knowledge of risk factors associated with survival, incomplete recovery and clinical relapse in MUO can help guide monitoring and treatment and improve owner communications regarding prognosis for this debilitating disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Science, Small Animal Teaching Hospital, University of Liverpool, Neston, UK.
- Department of Musculoskeletal and Ageing Science, Institute of Lifecourse and Medical Sciences, University of Liverpool, Neston, UK.
- Department of Clinical Science and Services, Royal Veterinary College, University of London, Hatfield, UK.
ORCID-Profile: Rita Gonçalves, Steven De Decker, Gemma Walmsley
Zitieren
APA
Gonçalves, R., De Decker, S., Walmsley, G., & Maddox, T. W. (2024). Prognosis in meningoencephalitis of unknown origin in dogs: Risk factors associated with survival, clinical relapse, and long-term disability. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17037
Vancouver
Gonçalves R, De Decker S, Walmsley G, Maddox TW. Prognosis in meningoencephalitis of unknown origin in dogs: Risk factors associated with survival, clinical relapse, and long-term disability. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17037
BibTeX
@article{Gonalves2024,
author = {Gonçalves, Rita and De Decker, Steven and Walmsley, Gemma and Maddox, Thomas W},
title = {Prognosis in meningoencephalitis of unknown origin in dogs: Risk factors associated with survival, clinical relapse, and long-term disability},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.17037}
}
EUVIMED